• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREJ2 CREATININE JAFFÉ GEN.2 - COMPENSATED METHOD FOR SERUM AND PLASMA; ALKALINE PICRATE, COLORIMETRY, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREJ2 CREATININE JAFFÉ GEN.2 - COMPENSATED METHOD FOR SERUM AND PLASMA; ALKALINE PICRATE, COLORIMETRY, CREATININE Back to Search Results
Model Number CREAJ
Device Problem Non Reproducible Results (4029)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/16/2019
Event Type  malfunction  
Manufacturer Narrative
The customer stated that the previous calibration values were slightly high in december with acceptable results and that after the recalibration, the values appeared closer to the expected values with acceptable results.The qc was in acceptable range the day of the event.The field service engineer verified the instruments performance and completed a 21-cup precision with acceptable results.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Event Description
The initial reporter received questionable crej2 creatinine jaffé gen.2 - compensated method for serum and plasma results, for 3 samples from the same patient, from the cobas integra 400 plus serial number (b)(4).Sample 1: the initial result was 0.84 mg/dl and the rerun result was 1.07 mg/dl.Sample 2: the initial result was 0.96 mg/dl and the rerun result was 1.23 mg/dl.Sample 3: the initial result was 1.32 mg/dl and the repeat result was 1.65 mg/dl.All initial results were obtained prior to the calibration of a new reagent and all repeat results were obtained after a calibration of a new reagent.The initial results were not believed to be correct.The questionable results were reported outside the laboratory.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREJ2 CREATININE JAFFÉ GEN.2 - COMPENSATED METHOD FOR SERUM AND PLASMA
Type of Device
ALKALINE PICRATE, COLORIMETRY, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key9559841
MDR Text Key216205855
Report Number1823260-2020-00085
Device Sequence Number1
Product Code CGX
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K941837
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberCREAJ
Device Catalogue Number04810716190
Device Lot Number324169
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/16/2019
Initial Date FDA Received01/07/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-